Analysis: Actos controls blood sugar, fat better than Avandia

09/20/2007 | Yahoo!

Takeda Pharmaceutical's diabetes drug Actos outperformed GlaxoSmithKline's Avandia in controlling blood sugar and lipid levels without increasing heart attack risks, researchers report. Actos also proved more effective in lowering LDL cholesterol levels and improving HDL cholesterol levels in an analysis of clinical trial data.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC